INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
My virtual meeting with Ian Rees at MHRA—why are gene therapies getting special treatment?

My virtual meeting with Ian Rees at MHRA—why are gene therapies getting special treatment?

Could it be to clear the way for wall-to-wall mRNA injections? This post is free :)

Hedley Rees's avatar
Hedley Rees
May 17, 2024
∙ Paid
10

Share this post

INSIDE PHARMA
INSIDE PHARMA
My virtual meeting with Ian Rees at MHRA—why are gene therapies getting special treatment?
4
Share

This is a repost from January 24, 2023

Ian Rees was the Manager for the Inspectorate Strategy and Innovation Unit and MHRA. I had a series of communications with him, and the Senior Regulatory Advisor, Inspection, Enforcement & Standards Division, nearly 18 months ago now.

At the end of the discussions, Ian Rees informed me he was about to retire. This is him today:

EX MHRA GMDP INSPECTOR IAN REES JOINS THE EPIC TEAM

by Epic-Admin Sep 1, 2023 0 Comment

pharmaceutical compliance

EPiC Auditors are thrilled to announce that Ian Rees, a renowned pharmaceutical compliance expert and former Expert MHRA GMDP Inspector, has joined our team as an independent consultant.

With an impressive career spanning over 40 years, twenty of which were with the MHRA, Ian brings a wealth of invaluable experience to our organisation.

That’s a strange kind of retirement? Game keeper come big Pharma poacher?

Anyway, this is what it was about.

Teams call today

I had a Microsoft Teams call with Ian Rees, MHRA’s Manager for the Inspectorate Strate…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share